Petros Pharmaceuticals, Inc. (PTPI) Gross margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) gross margin by fiscal year — reported gross profit divided by reported revenue.
76.3%FY2024 · since FY2020: 57.7% → 76.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 76.3% | +4.3 pp |
| FY2023 | 72.0% | +10.2 pp |
| FY2022 | 61.8% | -17.7 pp |
| FY2021 | 79.5% | +21.9 pp |
| FY2020 | 57.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice